NovaBay Pharmaceuticals, Inc. (NBY)

NovaBay Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.96	0.43	2.92	5.36	7.5
Cash & Short-Term Investments	7.96	0.43	2.92	5.36	7.5
Cash Growth	1750.70%	-85.29%	-45.47%	-28.54%	-37.22%
Accounts Receivable	-	-	0.68	1.97	1.67
Inventory	-	-	0.5	3.44	3.22
Other Current Assets	0.72	1.51	3.05	0.56	0.78
Total Current Assets	8.68	1.94	7.15	11.33	13.17
Net Property, Plant & Equipment	-	0.96	1.38	1.95	0.6
Other Intangible Assets	-	-	-	2.28	5.2
Goodwill	-	-	-	0.35	4.53
Other Long-Term Assets	0.36	0.53	0.5	0.49	0.48
Total Assets	9.04	3.42	9.03	16.4	23.98
Accounts Payable	0.26	0.11	0.91	1.08	1.05
Accrued Expenses	0.4	0.58	1.17	2.72	2.09
Short-Term Debt	-	0.5	-	-	0.11
Current Portion of Long-Term Debt	0.07	0.07	1.14	-	-
Current Portion of Leases	0.42	0.4	0.37	0.45	0.2
Other Current Liabilities	-	1.19	0.7	-	-
Total Current Liabilities	1.14	2.84	4.28	4.26	3.44
Long-Term Leases	0.29	0.71	1.11	1.59	0.25
Other Long-Term Liabilities	30.43	-	0.33	-	10.12
Total Long-Term Liabilities	30.72	0.71	1.44	1.59	10.37
Total Liabilities	31.86	3.55	5.72	5.85	13.81
Preferred Stock	0.01	0.01	1.95	2.97	0.68
Common Stock	0.25	0.01	0	0.02	0.48
Additional Paid-in Capital	186.98	183.31	176.21	165.71	150.9
Retained Earnings	-210.42	-183.46	-174.85	-158.15	-141.89
Total Common Shareholders' Equity	-23.18	-0.13	3.31	10.55	10.17
Minority Interest	0.35	-	-	-	-
Shareholders' Equity	-22.83	-0.13	3.31	10.55	10.17
Total Liabilities & Equity	9.04	3.42	9.03	16.4	23.98
Total Debt	0.78	1.67	2.61	2.04	0.55
Net Cash (Debt)	7.18	-1.24	0.31	3.32	6.95
Net Cash Growth	-	-	-90.64%	-52.24%	-39.27%
Net Cash Per Share	1.23	-1.83	12.96	360.98	975.76
Book Value	-23.18	-0.13	3.31	10.55	10.17
Book Value Per Share	-3.98	-0.19	138.08	1147.17	1427.37
Tangible Book Value	-23.18	-0.13	3.31	7.93	0.44
Tangible Book Value Per Share	-3.98	-0.19	138.08	861.52	62.17

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q